These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19732321)

  • 1. Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
    Miyake Y; Takaki A; Iwasaki Y; Yamamoto K
    J Viral Hepat; 2010 Apr; 17(4):287-92. PubMed ID: 19732321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
    Kobayashi S; Takeda T; Enomoto M; Tamori A; Kawada N; Habu D; Sakaguchi H; Kuroda T; Kioka K; Kim SR; Kanno T; Ueda T; Hirano M; Fujimoto S; Jomura H; Nishiguchi S; Seki S
    Liver Int; 2007 Mar; 27(2):186-91. PubMed ID: 17311612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders.
    Imai Y; Tamura S; Tanaka H; Hiramatsu N; Kiso S; Doi Y; Inada M; Nagase T; Kitada T; Imanaka K; Fukuda K; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2010 Mar; 17(3):185-91. PubMed ID: 19709362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
    Yang YF; Zhao W; Zhong YD; Xia HM; Shen L; Zhang N
    J Viral Hepat; 2009 Apr; 16(4):265-71. PubMed ID: 19220736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of patients with hepatitis C virus-related hepatocellular carcinoma occurring after interferon therapy.
    Komorizono Y; Sako K; Yamasaki N; Hiwaki T; Sakurai K; Shibatou T; Maeda M; Kohara K; Shigenobu S; Hasegawa S; Arima T; Oketani M; Ishibashi K; Arima T
    Anticancer Res; 2002; 22(6B):3573-8. PubMed ID: 12552958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy.
    Tokita H; Fukui H; Tanaka A; Kamitsukasa H; Yagura M; Harada H; Okamoto H
    J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors.
    Lin SM; Lin CJ; Hsu CW; Tai DI; Sheen IS; Lin DY; Liaw YF
    Cancer; 2004 Jan; 100(2):376-82. PubMed ID: 14716774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma.
    Akamatsu M; Yoshida H; Shiina S; Teratani T; Obi S; Tateishi R; Mine N; Kondo Y; Kawabe T; Omata M
    Liver Int; 2006 Jun; 26(5):536-42. PubMed ID: 16761997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
    J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.
    Sanefuji K; Kayashima H; Iguchi T; Sugimachi K; Yamashita Y; Yoshizumi T; Soejima Y; Nishizaki T; Taketomi A; Maehara Y
    J Surg Oncol; 2009 Jan; 99(1):32-7. PubMed ID: 18985618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor.
    Kanogawa N; Ogasawara S; Chiba T; Saito T; Motoyama T; Suzuki E; Ooka Y; Tawada A; Kanda T; Mikami S; Azemoto R; Kaiho T; Shinozaki M; Ohtsuka M; Miyazaki M; Yokosuka O
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1197-204. PubMed ID: 25682720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma.
    Qu LS; Jin F; Huang XW; Shen XZ
    J Surg Oncol; 2010 Dec; 102(7):796-801. PubMed ID: 20886584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
    Vezali E; Aghemo A; Lampertico P; Colombo M
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):455-64. PubMed ID: 21435968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma.
    Nishiguchi S; Tamori A; Kubo S
    Intervirology; 2005; 48(1):71-5. PubMed ID: 15785093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma.
    Wong JS; Wong GL; Tsoi KK; Wong VW; Cheung SY; Chong CN; Wong J; Lee KF; Lai PB; Chan HL
    Aliment Pharmacol Ther; 2011 May; 33(10):1104-12. PubMed ID: 21488914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interferon-alpha on recurrence and metastasis of hepatocellular carcinoma after curative resection in nude mice.
    Wang L; Tang Z; Xue Q; Sun H; Chen J; Gao D; Zhao Y; Chen J; Sun R; Liu Y; Ye S
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):154-6. PubMed ID: 11412390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
    Kudo M; Sakaguchi Y; Chung H; Hatanaka K; Hagiwara S; Ishikawa E; Takahashi S; Kitai S; Inoue T; Minami Y; Ueshima K
    Oncology; 2007; 72 Suppl 1():132-8. PubMed ID: 18087194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus.
    Singal AG; Volk ML; Jensen D; Di Bisceglie AM; Schoenfeld PS
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):280-8, 288.e1. PubMed ID: 19948249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.